Back to results
US 5,965,534 AGranted
Use of .omega.-conotoxin analogs for treating retinal and optic nerve head damage
AssigneeAlcon Laboratories, Inc.
InventorsIok-Hou Pang, Michael Kapin, Mark Hellberg
Life of this patent
Estimating the term…
Abstract
The invention is directed to the use of .omega.-conotoxins for the prevention and treatment of retinal or optic nerve head damage in humans. Compositions and methods are disclosed.
Claims9
A method for the prevention or treatment of retinal or optic nerve head damage resulting from acute traumatic or acute ischemic events which comprises administering intraocularly to a human patient a composition comprising a pharmaceutically effective amount of at least one .omega.-conotoxin and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.